Enline Announces Commercial Partnership with Microsoft

MicrosoftEnline plc, one of the UK's leading Identity and Access Management (IAM) solution providers, has announced it has become a Microsoft partner in the UK to deliver and sell Microsoft's health-specific IAM products. Enline has extensive knowledge of the health market and a clear vision of the benefits provided by solutions such as clinical context and user provisioning to NHS organisations.

The NHS is facing an incredible challenge to provide an ever increasing level of service while having to deal with continuing pressures on available budgets. Healthcare organisations are expected to operate more efficiently and improve the effectiveness of existing clinical systems whilst undergoing a period of transition. Providing Clinicians with the right patient data, appropriate to their role and in a format best suited to their requirements is core to the effort required to create these efficiencies.

In the UK, Microsoft's IAM portfolio consists of three products created specifically for healthcare organisations: expreSSO, a next-generation cost efficient single sign-on solution, Vergence, which unifies the single sign-on capability of expreSSO with context management, role-based access and strong authentication into a fully integrated clinical workstation and Microsoft proVision for automated centralised creation and management of network and application accounts. Collectively over 17 NHS trusts have signed contracts for IAM products from Microsoft to help deliver better clinical efficiency and reduced costs.

Whether used separately or collectively, the products enable the right people to access the right information at the right time. Microsoft has in the past year seen rapid enterprise-wide deployment with 17 NHS Trusts now using one or more Microsoft IAM products.

The addition of Enline represents an expansion in Microsoft's commercial strategy to adopt a channel approach that complements its existing direct to NHS approach.

John Gobron, Director Health Solutions Microsoft said: "We are pleased that Enline, as an IAM specialist with a wealth of experience in healthcare, has chosen to partner with Microsoft at such a critical time for the NHS. Healthcare organisations need to focus on vital issues of efficiency in infrastructure, people and outcomes and Enline will be delivering our innovative IAM products to help Trusts provide their clinicians with streamlined access to applications and patient data."

Mike Nelsey, Managing Director Enline plc said: "We are delighted to launch our association with Microsoft. Using solutions from Microsoft such as Clinical Context management and User Provisioning along with our wealth of experience, we can help Trusts to deliver a user-orientated approach to the challenge of multiple application logon, patient privacy and information delivery where and when it is needed."

Related news articles:

About Microsoft in Health
Microsoft is committed to improving health around the world through software innovation. Over the past 13 years, Microsoft has steadily increased its investments in health with a focus on addressing the challenges of health providers, health and social services organisations, payers, consumers and life sciences companies worldwide. Microsoft closely collaborates with a broad ecosystem of partners and delivers its own powerful health solutions, such as Amalga, HealthVault, and a portfolio of identity and access management technologies acquired from Sentillion Inc. in 2010. Together, Microsoft and its industry partners are working to deliver health solutions for the way people aspire to work and live.

About Microsoft
Founded in 1975, Microsoft (Nasdaq "MSFT") is the worldwide leader in software, services and solutions that help people and businesses realise their full potential.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...

Call for Papers: AI Applications in Biom…

JMIR Biomedical Engineering is inviting submissions for a new section titled "AI Applications in Biomedical Engineering." This themed section explores the integration of biomedical engineering and artificial intelligence (AI), focusing...